Drug Profile
Dinitrochlorobenzene
Alternative Names: DNCBLatest Information Update: 24 Oct 2021
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Class Antineoplastics; Antivirals; Nitrobenzenes
- Mechanism of Action Th1 cell stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Alopecia; Atopic dermatitis; HIV infections; Malignant melanoma; Systemic lupus erythematosus
Most Recent Events
- 12 Apr 2000 A study in patients with atopic dermatitis has been added to the Skin disorders therapeutic trials section
- 03 Apr 2000 Investigation in Atopic dermatitis in Japan (Topical)
- 30 Jul 1998 A controlled, quality of life analysis has been added to the Viral infections therapeutic trials section